The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
The potential chemical structure of anti‐SARS‐CoV‐2 RNA‐dependent RNA polymerase
Open accessAbstract
An outbreak of coronavirus disease 2019 (COVID‐19) occurred in Wuhan and it has rapidly spread to almost all parts of the world. For coronaviruses, RNA‐dependent RNA polymerase (RdRp) is an important polymerase that catalyzes the replication of RNA from RNA template and is an attractive therapeutic target. In this study, we screened these chemical structures from traditional Chinese medicinal compounds proven to show antiviral activity in severe acute respiratory syndrome coronavirus (SARS‐CoV) and the similar chemical structures through a molecular docking study to target RdRp of SARS‐CoV‐2, SARS‐CoV, and Middle East respiratory syndrome coronavirus (MERS‐CoV). We found that theaflavin has a lower idock score in the catalytic pocket of RdRp in SARS‐CoV‐2 (−9.11 kcal/mol), SARS‐CoV (−8.03 kcal/mol), and MERS‐CoV (−8.26 kcal/mol) from idock. To confirm the result, we discovered that theaflavin has lower binding energy of −8.8 kcal/mol when it docks in the catalytic pocket of SARS‐CoV‐2 RdRp by using the Blind Docking server. Regarding contact modes, hydrophobic interactions contribute significantly in binding and additional hydrogen bonds were found between theaflavin and RdRp. Moreover, one π‐cation interaction was formed between theaflavin and Arg553 from the Blind Docking server. Our results suggest that theaflavin could be a potential SARS‐CoV‐2 RdRp inhibitor for further study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
UCSF Chimera—A visualization system for exploratory research and analysis
Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20084 · Cited by 45,828
SWISS-MODEL: homology modelling of protein structures and complexes
Waterhouse, A., Bertoni, M., Bienert, S., Studer, G., Tauriello, G., Gumienny, R., Heer, F. T., de Beer, T. A. P., Rempfer, C., Bordoli, L., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky427 · Cited by 13,067
First case of 2019 novel coronavirus in the United States
Holshue, M. L., DeBolt, C., Lindquist, S., Lofy, K. H., Wiesman, J., Bruce, H., Spitters, C., Ericson, K., Wilkerson, S., Tural, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001191 · Cited by 6,030
Protein Structure Modeling with MODELLER
Eswar, N., Eramian, D., Webb, B., Shen, M.-Y., & Sali, A. (2008) · Methods in Molecular Biology · doi:10.1007/978-1-60327-058-8_8 · Cited by 1,773
Potential interventions for novel coronavirus in China: A systematic review
Zhang, L., & Liu, Y. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25707 · Cited by 1,348
Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus
Cinatl, J., Morgenstern, B., Bauer, G., Chandra, P., Rabenau, H., & Doerr, H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13615-x · Cited by 1,158
Gordon, C. J., Tchesnokov, E. P., Feng, J. Y., Porter, D. P., & Götte, M. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ac120.013056 · Cited by 850
Morse, J. S., Lalonde, T., Xu, S., & Liu, W. R. (2020) · ChemBioChem · doi:10.1002/cbic.202000047 · Cited by 776
Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir
Tchesnokov, E. P., Feng, J. Y., Porter, D. P., & Götte, M. (2019) · Viruses · doi:10.3390/v11040326 · Cited by 622
Biflavonoids from Torreya nucifera displaying SARS-CoV 3CLpro inhibition
Ryu, Y. B., Jeong, H. J., Kim, J. H., Kim, Y. M., Park, J.-Y., Kim, D., Naguyen, T. T. H., Park, S.-J., Chang, J. S., Park, K. H., et al. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.09.035 · Cited by 546
Small Molecules Blocking the Entry of Severe Acute Respiratory Syndrome Coronavirus into Host Cells
Yi, L., Li, Z., Yuan, K., Qu, X., Chen, J., Wang, G., Zhang, H., Luo, H., Zhu, L., Jiang, P., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.20.11334-11339.2004 · Cited by 485
Natural product-derived phytochemicals as potential agents against coronaviruses: A review
Mani, J. S., Johnson, J. B., Steel, J. C., Broszczak, D. A., Neilsen, P. M., Walsh, K. B., & Naiker, M. (2020) · Virus Research · doi:10.1016/j.virusres.2020.197989 · Cited by 450
Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
Park, J.-Y., Kim, J. H., Kim, Y. M., Jeong, H. J., Kim, D. W., Park, K. H., Kwon, H.-J., Park, S.-J., Lee, W. S., & Ryu, Y. B. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.07.038 · Cited by 258
Inhibition of SARS‐CoV 3C‐like Protease Activity by Theaflavin‐3,3′‐digallate (TF3)
Chen, C.-N., Lin, C. P. C., Huang, K.-K., Chen, W.-C., Hsieh, H.-P., Liang, P.-H., & Hsu, J. T.-A. (2005) · Evidence-Based Complementary and Alternative Medicine · doi:10.1093/ecam/neh081 · Cited by 239
Analyzing the epidemiological outbreak of COVID‐19: A visual exploratory data analysis approach
Dey, S. K., Rahman, M. M., Siddiqi, U. R., & Howlader, A. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25743 · Cited by 186
Antiviral effects of probiotic metabolites on COVID-19
Anwar, F., Altayb, H. N., Al-Abbasi, F. A., Al‐Malki, A. L., Kamal, M. A., & Kumar, V. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1775123 · Cited by 155
Dariya, B., & Nagaraju, G. P. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.05.001 · Cited by 105
Effect of integrated traditional Chinese and Western medicine on SARS: A review of clinical evidence
Zhang, M., Liu, X.-M., & He, L. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i23.3500 · Cited by 85
Cited by
Sun, W., & Shahrajabian, M. H. (2023) · Molecules · doi:10.3390/molecules28041845 · Cited by 806
Natural product-derived phytochemicals as potential agents against coronaviruses: A review
Mani, J. S., Johnson, J. B., Steel, J. C., Broszczak, D. A., Neilsen, P. M., Walsh, K. B., & Naiker, M. (2020) · Virus Research · doi:10.1016/j.virusres.2020.197989 · Cited by 450
Nanotechnology for COVID-19: Therapeutics and Vaccine Research
Chauhan, G., Madou, M. J., Kalra, S., Chopra, V., Ghosh, D., & Martinez-Chapa, S. O. (2020) · ACS Nano · doi:10.1021/acsnano.0c04006 · Cited by 385
C, S., S., D. K., Ragunathan, V., Tiwari, P., A., S., & P, B. D. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1815584 · Cited by 375
Zhang, Y., Cai, P., Cheng, G., & Zhang, Y. (2022) · Natural Product Communications · doi:10.1177/1934578x211069721 · Cited by 335
Metadata
- Authors
- Lung, J., Lin, Y., Yang, Y., Chou, Y., Shu, L., Cheng, Y., Liu, H. T., & Wu, C.
- Venue
- Journal of Medical Virology
- Publisher
- Wiley
- Published
- 2020-03-18
- Volume
- 92
- Issue
- 6
- Pages
- 693-697
- ISSN
- 0146-6615 (ISSN-L)
- 1096-9071
- OpenAlex
- W3011848620
- Cited by
- 295
- References
- 18
- FWCI
- 33.11
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.